π¨ WHO Prequalifies Mpox Vaccine π¨
WHO added Bavarian Nordicβs Imvanex to its prequalified vaccines listβa key step in fighting mpox.
π. 103k+ cases in 120+ countries since 2022. Imvanex: 76% effective (1 dose), 82% (2 doses). Big win for Africa & global health! ππͺ. #Mpox
π Proud to be a Silver Sponsor at the Clinical Research Society of Kenya Gala! At ACE Research, we're committed to advancing global health research. Excited to connect with industry leaders and celebrate miracles of research! #CRSKGala#ClinicalResearch#Kenya#ClinicalTrials
Thanks to VIBRI Consortium for recognizing our efforts! At the recent investigator meeting in Rwanda, we marked a key milestone in our study on COVID-19 vaccine boosters for those living with HIV. These findings will help optimize vaccination schedules globally. #COVID19
π We're exhibiting at World Vaccine Congress 2024! π
ποΈ April 1-4, 2024 | Walter E. Washington Convention Center, D.C. | Booth 362
Interested in vaccine trials in Sub-Saharan Africa? Let's chat! Schedule a meeting π https://t.co/uVQ4bIRcNd
#WVC2024
ππ Kudos to @EmergexVaccines for medical countermeasures against #dengue! With over 5 million cases & 5,000+ deaths in 2023WHO estimates, your groundbreaking work is more crucial than ever. Excited for the life-changing impact of your research. #GlobalHealth#biotech
Day 2 at #ASH2023 featured insightful sessions on sickle cell disease. Experts discussed new gene therapies and pain management techniques. Exciting progress is being made in this area, and weβre looking forward to more in the coming days.#sicklecell
ACE Research is attending the American Society of Hematology conference in San Diego. Connect with our expert team and learn how we partner with industry and CROs to develop latest research and products in the field of hematology. #ASH2023#Hematology#Research#sicklecell
ππ¦ Happy Thanksgiving from our ACE Research family to yours! Grateful for a year of growth, our incredible team, and our amazing community. Thank you for being part of our journey. Excited for what's ahead! π
#HappyThanksgiving#Gratitude#TeamSpirit#clinicalresearch π§‘π
Dr. Shweta Brahmbhatt - VIBRI Africa COVID-19 consortium Project Manager discusses lessons learnt. Collaboration and partnerships between local consortium members are critical for the successful conduct of multi-country clinical trials in Africa.
Excited to announce that ACE Research is coordinating VIBRI Africa COVID-19 consortium investigator meeting at Sarova Imperial Hoetl in Kisumu, Kenya. Proud to network with our site teams from University of Kinshasa, Rinda Ubuzima , Rwanda and VIBRI, Kenya
Investigator site budget negotiations is one of the most challenging aspects and can delay start up. Here are five importance determinants of investigator site budget in Africa.
Talk to an expert. https://t.co/9l0GIUKAgr
It's not just about better engagement withΒ patientsΒ as study subjects: GettingΒ patientΒ input into studies is foundational in order to optimize recruitment, retention and follow up.
Please ππ» π β€οΈ β
Join us in this years Clinical Trials Day Celebration π! Clinical trials plays a critical role in delivering live changing treatments to patients. We celebrate all research professionals for the race to COVID-19 medical countermeasures.
#clinicaltrialsday
With a good CRO partner, you can dramatically improve your success rate when it comes to safely delivering vaccine clinical trials in compliance with requirements of GCP.
Talk to an expert: https://t.co/9l0GIUKAgr
#covid-19 #clinicaltrial#clinicalresearch